A cluster analysis demonstrated the potential for the Multiple Sleep Latency Test (MSLT) to aid in the diagnosis of central hypersomnia and distinguish between idiopathic hypersomnia subgroups.
The Multiple Sleep Latency Test (MSLT) has demonstrated promise for diagnosing central hypersomnia and potentially identifying idiopathic hypersomnia subgroups, according to a study published in Frontiers Psychiatry.
Sleep Disorders Graphic | image credit: ibreakstock - stock.adobe.com
Central hypersomnia, including narcolepsy types 1 and 2 (NT1, NT2) and idiopathic hypersomnia (IH), is the main driver of excessive daytime sleepiness (EDS), which is symptomatic of multiple sleeping disorders. To date, the pathophysiology of disorders such as NT1 are well-understood and characterized; however, there is insufficient knowledge documenting the characteristics of IH and NT2. This gap of knowledge creates obstacles for diagnosing central hypersomnia, as well as distinguishing between the disorders within this classification.
The MSLT is a validated, useful tool for evaluating the features and symptoms of central hypersomnia. This measure assesses how easy it is for one to fall asleep to represent EDS severity. Over the course of 4-5 naps, the MSLT derives a mean sleep latency (mSL) to draw conclusions, with an mSL of 8 minutes constituting the threshold for diagnosing central hypersomnia. There are additional parameters to the MSLT that the authors of the present study deemed underutilized in clinical decision-making that could aid in the differentiation of central hypersomnia: incidence of the sleep-onset rapid eye movement period (SOREMP, which is a measure of NT1 and NT2), as well as sleep latency variation and absolute length of msL.
To expand on the literature regarding central hypersomnia, the researchers conducted a study using the underutilized measures of the MSLT with hopes of distinguishing central hypersomnia. Additionally, the team used these MSLT parameters to learn about the presence of attention deficit hyperactive disorder (ADHD) in their patients because, they added, ADHD can often be tangled up with sleep disorders such as EDS. Elucidating this relationship further could aid clinical understandings of the impacts of coexisting ADHD in sleep health.
Data were gathered between January 2020 and December 2021 from patients with EDS at the Sunao Clinic, Saitama, Japan, who had MSLT.
A total of 200 patients were eligible for the analysis. From this group, there were 139 patients with a central hypersomnia diagnosis, of which there were 97 with IH, 25 with NT2, and 17 with NT1, respectively. The 61 other patients did not meet the central hypersomnia criteria. Additionally, 93 patients were diagnosed with ADHD and the remaining 107 were classified as typically developing.
In their analysis, the researchers distinguished 9 clusters. Within Clusters 1 and 3, there was a large proportion of MSLT-positive results. The entirety of Cluster 2 was MSLT-positive. A mix of results were observed in Cluster 7 and results were predominantly MSLT-negative throughout Clusters 4, 5, 6, 8, and 9. The authors noted a high degree of variability in hypersomnia diagnosis within Clusters 1, 2, 3, and 7. Furthermore, there was a significant association between individuals in Cluster 2 and a diagnosis of NT1 and NT2 (P < .005).
There was not a significant relationship between ADHD diagnoses and an individual’s sleep latency pattern; however, the authors noted that they found some hints that ADHD could influence these patterns. Nor was the cluster analysis able to differentiate between IH and NT2.
As the authors concluded, they emphasized the potential for unused MSLT parameters to aid in the identification of subgroups of idiopathic hypersomnia. For future studies, larger cohorts with a greater proportion of participants with ADHD should be considered to broaden clinical understandings of the relationship between ADHD and sleep patterns.
Reference
Maruo T, Takagi S, Uchida S, Takahashi H, Sugihara G. Temporal patterns of sleep latency in central hypersomnia and attention deficit hyperactivity disorder: a cluster analysis exploration using Multiple Sleep Latency Test. Front Psychiatry. 2024;15:1361140. doi:10.3389/fpsyt.2024.1361140
Symptom Documentation Differences in Acute Cancer Care Suggest Sociodemographic Disparities
April 22nd 2025Researchers are calling for more targeted efforts to improve health equity after a new analysis revealed that cancer symptom documentation and burden vary across certain demographics.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More